Luca Masucci

Medicine & Life Sciences

1. Fecal Microbiota Transplantation 100%
2. Clostridium Infections 66%
3. Gastrointestinal Microbiome 37%
4. Vancomycin 27%
5. Clostridium difficile 26%
6. Colonoscopy 24%
7. Microbiota 22%
8. Randomized Controlled Trials 20%
9. Helicobacter pylori 17%
10. Infection with Mycobacterium marinum 15%
11. Anti-Bacterial Agents 14%
12. Parasites 12%
13. Gastrointestinal Diseases 10%
14. Critical Pathways 10%
15. Proton Pump Inhibitors 10%
16. Feces 10%
17. Diarrhea 10%
18. actoxumab 10%
19. Therapeutics 9%
20. Italy 9%
21. Bacteriophages 9%
22. Congresses 9%
23. bezlotoxumab 8%
24. Polymerase Chain Reaction 8%
25. black widow spider venom 8%
26. Bacteria 8%
27. Monoclonal Antibodies 8%
28. Infections 8%
29. poly(beta-D-mannuronate) lyase 8%
30. alpha-latrotoxin 8%
31. Pseudomembranous Enterocolitis 7%
32. Ribotyping 7%
33. Helicobacter Infections 7%
34. boric acid 7%
35. Mycolic Acids 7%
36. Furocoumarins 7%
37. Entamoeba histolytica 7%
38. Length of Stay 7%
39. Rifaximin 6%
40. Adopted Children 6%
41. Inflammatory Bowel Diseases 6%
42. Entamoeba 6%
43. Referral and Consultation 6%
44. Irritable Bowel Syndrome 6%
45. Immunoglobulin Fragments 6%
46. Cohort Studies 6%
47. Candida 6%
48. Tissue Donors 6%
49. Teaching Hospitals 6%
50. Black Widow Spider 6%